View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
  2. Software
November 23, 2015

UK Gov’t pledges £1 billion to Bill Gates malaria fight

News: The Microsoft founder has been battling malaria since 2013 as part of the 'Accelerate to Zero' strategy.

By Alexander Sword

The UK Government is working with the Bill and Melinda Gates Foundation to tackle malaria as part of a new overseas aid commitment.

Chancellor George Osborne is set to announce a £1 billion fund to tackle malaria and other diseases as part of the Autumn spending review, which will be delivered in partnership with the Microsoft founder’s charity.

The package includes £90 million for the eradication of malaria implementation, £100 million in support for research and development of products for infectious diseases and £115 to develop new drugs, diagnostics and insecticides.

The Foundation itself has committed around $2 billion in grants to combat malaria, as part of a multi-year strategy called Accelerate to Zero that it adopted in late 2013.

"With the combined skill and expertise of British scientists; leveraging the weight of both public and private financing; and the continued leadership of George Osborne and the UK, today’s announcement of the Ross Fund will play a key role in reaching that goal," said Gates.

Content from our partners
Scan and deliver
GenAI cybersecurity: "A super-human analyst, with a brain the size of a planet."
Cloud, AI, and cyber security – highlights from DTX Manchester

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
THANK YOU